A carregar...
Toxicity of Cancer Therapy: What the Cardiologist Needs to Know about Angiogenesis Inhibitors
Clinical outcomes for patients with a wide range of malignancies have improved substantially over the last two decades. Tyrosine kinase inhibitors (TKI) are potent signalling cascade inhibitors and have been responsible for significant advances in cancer therapy. By inhibiting vascular endothelial g...
Na minha lista:
| Publicado no: | Heart |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6268130/ https://ncbi.nlm.nih.gov/pubmed/30228246 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/heartjnl-2018-313726 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|